Neoleukin Therapeutics, Inc.
NLTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,953 | -$22,016 | -$22,647 | -$54,329 |
| Dep. & Amort. | $776 | $767 | $762 | $1,880 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,365 | $3,408 | $4,048 | $6,626 |
| Change in WC | $0 | $0 | $0 | $5,234 |
| Other Non-Cash | -$2,696 | -$1,621 | -$2,937 | -$8,663 |
| Operating Cash Flow | -$19,508 | -$19,462 | -$20,774 | -$49,252 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$127 | -$148 | -$780 | -$257 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$77,383 | -$60,402 | -$88,965 | -$106,570 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$99,000 |
| Other Inv. Act. | $99,500 | $68,000 | $44,700 | $71,885 |
| Investing Cash Flow | $21,990 | $7,450 | -$45,045 | -$133,942 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,800 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,710 | $54 | $4 | $184,432 |
| Financing Cash Flow | $9,710 | $54 | $4 | $184,432 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $12,192 | -$11,958 | -$65,815 | $111,191 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59,152 | $71,110 | $136,925 | $25,734 |
| End Cash | $71,344 | $59,152 | $71,110 | $136,925 |
| Free Cash Flow | -$19,635 | -$19,610 | -$21,554 | -$49,509 |